Re: Zenith MD&A posted to SEDAR 8/23/18

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith MD&A posted to SEDAR 8/23/18

in response to

Re: Zenith MD&A posted to SEDAR 8/23/18

Toinv

posted on Sep 01, 2018 01:35PM

Toinv - You will likely get answers to a number of your questions within the next two weeks given the AGM usually has a webcast'd presentation. If we don't get an answer to your last question I'll do my best to remember to ask it in the Q&A.